Related Experiment Videos

Effects of glutathione or polyamine depletion on in vivo thermosensitization

D T Laskowitz1, G B Elion, M W Dewhirst

  • 1Department of Pathology, Duke University Medical Center, Durham, NC 27705.

Insights

Glutathione depletion enhanced hyperthermia

Area of Science:

  • Oncology
  • Cancer Research
  • Pharmacology

Background:

  • Rhabdomyosarcoma xenografts TE-671 and TE-671 MR are used to study melphalan sensitivity.
  • Glutathione and polyamine levels influence cellular responses to therapy.
  • Thermosensitivity is a potential target in cancer treatment.

Purpose of the Study:

  • To investigate the impact of glutathione and polyamine modulation on the thermosensitivity of rhabdomyosarcoma xenografts.
  • To determine if depleting glutathione or polyamines enhances hyperthermia efficacy in vivo.
  • To compare in vivo findings with previous in vitro studies.

Main Methods:

  • Glutathione depletion using L-buthionine-S,R-sulfoximine in TE-671 and TE-671 MR xenografts.
  • Polyamine depletion using MDL 72.175DA, an ornithine decarboxylase inhibitor.
  • Exposure of xenografts to hyperthermia (42°C or 43°C) with or without drug treatment.
  • Assessment of tumor growth delays and cytotoxicity.

Main Results:

  • Glutathione depletion alone did not enhance hyperthermia-induced growth delays.
  • Buthionine sulfoximine-mediated glutathione depletion significantly increased hyperthermia cytotoxicity only in TE-671 MR at 43°C.
  • Polyamine depletion with MDL 72.175DA did not result in significant growth delays, even with hyperthermia.
  • Intracellular putrescine and spermidine levels were reduced, but spermine levels remained unchanged after polyamine depletion.

Conclusions:

  • Glutathione depletion shows limited efficacy in enhancing hyperthermia treatment for rhabdomyosarcoma xenografts in vivo.
  • Polyamine depletion does not appear to sensitize these xenografts to hyperthermia in the tested conditions.
  • Further research is required to understand the discrepancies between in vitro and in vivo results and to optimize combination therapies.

Related Concept Videos